These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35502113)

  • 1. Noninflammatory thyroid eye disease in Indian subcontinent: Is it a departure from Rundle's curve?
    Agarwal A; Khanam S; Shah S; Raut A
    Indian J Ophthalmol; 2022 May; 70(5):1866-1867. PubMed ID: 35502113
    [No Abstract]   [Full Text] [Related]  

  • 2. Spontaneous improvement of untreated mild Graves' ophthalmopathy: Rundle's curve revisited.
    Menconi F; Profilo MA; Leo M; Sisti E; Altea MA; Rocchi R; Latrofa F; Nardi M; Vitti P; Marcocci C; Marinò M
    Thyroid; 2014 Jan; 24(1):60-6. PubMed ID: 23980907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between thyroid eye disease and radioiodine treatment.
    Thou S; Vinjamuri S
    Nucl Med Commun; 2019 Mar; 40(3):194-198. PubMed ID: 30614922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical assessment of patients with thyroid eye disease.
    Karra E; Yousseif A; Rose GE; Baldeweg SE
    Br J Hosp Med (Lond); 2016 Jan; 77(1):C2-5. PubMed ID: 26903467
    [No Abstract]   [Full Text] [Related]  

  • 5. Thyroid eye disease survey: An anonymous web-based survey in the Indian subcontinent.
    Pradhan A; Ganguly A; Naik MN; Nair AG; Desai S; Rath S
    Indian J Ophthalmol; 2020 Aug; 68(8):1609-1614. PubMed ID: 32709788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Commentary: Thyroid eye disease-does the profile differ in India?
    Grover AK
    Indian J Ophthalmol; 2020 Aug; 68(8):1635. PubMed ID: 32709795
    [No Abstract]   [Full Text] [Related]  

  • 7. Graves' Ophthalmopathy in a Paediatric Population.
    Sadeghi Y; Obéric A; Theintz G; Hamédani M
    Klin Monbl Augenheilkd; 2017 Apr; 234(4):591-594. PubMed ID: 28329893
    [No Abstract]   [Full Text] [Related]  

  • 8. Commentary: Risk factors predicting visual morbidity in thyroid eye disease.
    Rath S
    Indian J Ophthalmol; 2020 Aug; 68(8):1627-1628. PubMed ID: 32709793
    [No Abstract]   [Full Text] [Related]  

  • 9. Commentary: Thyroid eye disease in India: A wake-up call?
    Mukherjee B
    Indian J Ophthalmol; 2020 Aug; 68(8):1614-1615. PubMed ID: 32709789
    [No Abstract]   [Full Text] [Related]  

  • 10. [Graves' orbitopathy: diagnosis, epidemiology and treatments].
    Lun AY; Le Bras M; Scharbarg E; Morcel P; Hadjadj S; Lebranchu P; Drui D
    Rev Med Interne; 2022 Apr; 43(4):242-251. PubMed ID: 35221112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticosteroids in Moderate-To-Severe Graves' Ophthalmopathy: Oral or Intravenous Therapy?
    Penta L; Muzi G; Cofini M; Leonardi A; Lanciotti L; Esposito S
    Int J Environ Res Public Health; 2019 Jan; 16(1):. PubMed ID: 30626069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies targeting the calcium binding skeletal muscle protein calsequestrin are specific markers of ophthalmopathy and sensitive indicators of ocular myopathy in patients with Graves' disease.
    Gopinath B; Musselman R; Beard N; El-Kaissi S; Tani J; Adams CL; Wall JR
    Clin Exp Immunol; 2006 Jul; 145(1):56-62. PubMed ID: 16792674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid eye disease: a review.
    Weiler DL
    Clin Exp Optom; 2017 Jan; 100(1):20-25. PubMed ID: 27701774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of open-angle glaucoma, glaucoma suspect, and ocular hypertension in thyroid-related immune orbitopathy.
    Skalicky SE; Borovik AM; Masselos K; Pandya VB; Wang LW; Figueira EC; Wilcsek G; Francis IC
    J Glaucoma; 2008; 17(3):249; author reply 249-50. PubMed ID: 18414116
    [No Abstract]   [Full Text] [Related]  

  • 15. Thyroid eye disease for the primary care physician.
    Phelps PO; Williams K
    Dis Mon; 2014 Jun; 60(6):292-8. PubMed ID: 24906675
    [No Abstract]   [Full Text] [Related]  

  • 16. Critical issues on Graves' ophthalmopathy.
    Rocchi R
    MLO Med Lab Obs; 2006 May; 38(5):10-2, 14-5; quiz 16-7. PubMed ID: 16761864
    [No Abstract]   [Full Text] [Related]  

  • 17. Thyroid Orbitopathy.
    Wang Y; Tooley AA; Mehta VJ; Garrity JA; Harrison AR; Mettu P
    Int Ophthalmol Clin; 2018; 58(2):137-179. PubMed ID: 29517649
    [No Abstract]   [Full Text] [Related]  

  • 18. Visual morbidity in thyroid eye disease in Asian Indian patients.
    Gupta R; Thomas R; Almukhtar F; Kiran A
    Indian J Ophthalmol; 2020 Aug; 68(8):1622-1627. PubMed ID: 32709792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Childhood Graves' ophthalmopathy: results of a European questionnaire study.
    Krassas GE; Segni M; Wiersinga WM
    Eur J Endocrinol; 2005 Oct; 153(4):515-21. PubMed ID: 16189172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymmetric Graves' Orbitopathy.
    Panagiotou G; Perros P
    Front Endocrinol (Lausanne); 2020; 11():611845. PubMed ID: 33391188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.